Se hai scelto di non accettare i cookie di profilazione e tracciamento, puoi aderire all’abbonamento "Consentless" a un costo molto accessibile, oppure scegliere un altro abbonamento per accedere ad ANSA.it.

Ti invitiamo a leggere le Condizioni Generali di Servizio, la Cookie Policy e l'Informativa Privacy.

Puoi leggere tutti i titoli di ANSA.it
e 10 contenuti ogni 30 giorni
a €16,99/anno

  • Servizio equivalente a quello accessibile prestando il consenso ai cookie di profilazione pubblicitaria e tracciamento
  • Durata annuale (senza rinnovo automatico)
  • Un pop-up ti avvertirà che hai raggiunto i contenuti consentiti in 30 giorni (potrai continuare a vedere tutti i titoli del sito, ma per aprire altri contenuti dovrai attendere il successivo periodo di 30 giorni)
  • Pubblicità presente ma non profilata o gestibile mediante il pannello delle preferenze
  • Iscrizione alle Newsletter tematiche curate dalle redazioni ANSA.


Per accedere senza limiti a tutti i contenuti di ANSA.it

Scegli il piano di abbonamento più adatto alle tue esigenze.

Toxicologists meet in New Orleans

Toxicologists meet in New Orleans

Philip Morris presents new cigarette alternative

New Orleans, 15 March 2016, 17:11

ANSA Editorial

ANSACheck

More than 6,500 toxicologists are convening in New Orleans for the Society of Toxicology's 55th edition of its global meeting aimed at developing research into the adverse effects of chemicals on the human body.
    Scientists and experts are taking part in plenary sessions, workshops and round-tables discussing the latest technological innovations and research themes.
    The March 13-17 meeting is also hosting ToxExpo, the biggest exhibition dedicated to toxicology and related biomedical sciences, which includes more than 350 exhibitors.
    U.S. cigarette and tobacco company Philip Morris International is presenting a study of its "Heat Not Burn" cigarette alternative.
    The iQOS device heats sticks containing tobacco, and the company says it could reduce risks compared to smoking because it does not rely on combustion.
    Studies have shown that combustion in cigarettes, with the harmful substances the process emits, is a principle cause of illness linked to smoking.
    The Philip Morris study shows that the iQOS can reduce the formation of harmful and potentially harmful substances by 90% on average compared to a standard cigarette.
    It is due to submit the research to the U.S. Food and Drug Administration by the end of 2016.
   

ALL RIGHTS RESERVED © Copyright ANSA

Not to be missed

Share

Or use

ANSA Corporate

If it is news,
it is an ANSA.

We have been collecting, publishing and distributing journalistic information since 1945 with offices in Italy and around the world. Learn more about our services.